HUP0202793A2 - A humán inzulin monomer analógjai - Google Patents
A humán inzulin monomer analógjaiInfo
- Publication number
- HUP0202793A2 HUP0202793A2 HU0202793A HUP0202793A HUP0202793A2 HU P0202793 A2 HUP0202793 A2 HU P0202793A2 HU 0202793 A HU0202793 A HU 0202793A HU P0202793 A HUP0202793 A HU P0202793A HU P0202793 A2 HUP0202793 A2 HU P0202793A2
- Authority
- HU
- Hungary
- Prior art keywords
- human insulin
- monomeric
- monomeric analogues
- analogues
- chain
- Prior art date
Links
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 title abstract 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Humán inzulin monomer analógok, melyek a humán inzulin B-láncának 12.,16. és 26. helyzetében aminosav helyettesítéseket tartalmaznak, ésamelyek a B-lánc végein deléciókat is tartalmaznak. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99116851A CN1125081C (zh) | 1999-09-08 | 1999-09-08 | 重组天然和新型人胰岛素及其制备方法 |
| PCT/GB2000/003460 WO2001018052A1 (en) | 1999-09-08 | 2000-09-08 | Monomeric analogues of human insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0202793A2 true HUP0202793A2 (hu) | 2002-12-28 |
| HUP0202793A3 HUP0202793A3 (en) | 2005-07-28 |
Family
ID=5279521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0202793A HUP0202793A3 (en) | 1999-09-08 | 2000-09-08 | Monomeric analogues of human insulin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6800606B1 (hu) |
| EP (1) | EP1210369A1 (hu) |
| JP (1) | JP2003525867A (hu) |
| CN (1) | CN1125081C (hu) |
| AU (1) | AU767006B2 (hu) |
| BR (1) | BR0013840A (hu) |
| CA (1) | CA2383638A1 (hu) |
| CZ (1) | CZ20021227A3 (hu) |
| HU (1) | HUP0202793A3 (hu) |
| IL (1) | IL148380A0 (hu) |
| MX (1) | MXPA02002489A (hu) |
| NO (1) | NO20021135D0 (hu) |
| PL (1) | PL354488A1 (hu) |
| TR (1) | TR200200599T2 (hu) |
| WO (1) | WO2001018052A1 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR025646A1 (es) * | 2000-09-13 | 2002-12-04 | Beta Lab Sa | Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa. |
| US7833513B2 (en) | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| ES2665853T3 (es) | 2012-03-29 | 2018-04-27 | Biocon Limited | Secreción de insulina glargina funcional directamente en el medio de cultivo mediante la sobreexpresión intracelularmente de Kex2p |
| CN102703552B (zh) * | 2012-05-15 | 2014-10-29 | 山东阿华生物药业有限公司 | 重组人胰岛素的制备方法及其产品 |
| CN102816819B (zh) * | 2012-08-13 | 2014-10-29 | 山东阿华生物药业有限公司 | 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法 |
| BR112019011860A2 (pt) * | 2016-12-09 | 2019-11-12 | Akston Biosciences Corp | proteína de fusão insulina-fc, sequência de ácido nucleico recombinante que codifica a mesma, vetor, célula eucariótica modificada, kit e método para tratar ou prevenir o diabetes autoimune |
| JP7457023B2 (ja) | 2018-08-20 | 2024-03-27 | バイオコン バイオロジクス リミテッド | インスリンアナログの精製のためのクロマトグラフィープロセス |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3033127A1 (de) | 1980-09-03 | 1982-04-08 | Hoechst Ag, 6000 Frankfurt | Neue analoga des insulins |
| DK58285D0 (da) | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
| PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DE3717370A1 (de) | 1987-05-22 | 1988-12-01 | Hoechst Ag | Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus |
| NZ232375A (en) * | 1989-02-09 | 1992-04-28 | Lilly Co Eli | Insulin analogues modified at b29 |
| CA2151134A1 (en) * | 1992-12-18 | 1994-07-07 | Ronald Eugene Chance | Insulin analogs |
| CN1044856C (zh) | 1993-10-19 | 1999-09-01 | 中国科学院上海有机化学研究所 | 果聚糖同系混合物的药物、生产方法及其用途 |
| YU18596A (sh) | 1995-03-31 | 1998-07-10 | Eli Lilly And Company | Analogne formulacije monomernog insulina |
| SK12412000A3 (sk) * | 1998-02-23 | 2002-05-09 | Neurocrine Biosciences, Inc. | Metódy liečenia diabetu použitím peptidových analógov inzulínu |
-
1999
- 1999-09-08 CN CN99116851A patent/CN1125081C/zh not_active Expired - Fee Related
-
2000
- 2000-09-08 HU HU0202793A patent/HUP0202793A3/hu unknown
- 2000-09-08 JP JP2001522274A patent/JP2003525867A/ja active Pending
- 2000-09-08 CZ CZ20021227A patent/CZ20021227A3/cs unknown
- 2000-09-08 MX MXPA02002489A patent/MXPA02002489A/es active IP Right Grant
- 2000-09-08 CA CA002383638A patent/CA2383638A1/en not_active Abandoned
- 2000-09-08 US US10/070,568 patent/US6800606B1/en not_active Expired - Fee Related
- 2000-09-08 BR BR0013840-1A patent/BR0013840A/pt not_active Application Discontinuation
- 2000-09-08 TR TR2002/00599T patent/TR200200599T2/xx unknown
- 2000-09-08 IL IL14838000A patent/IL148380A0/xx unknown
- 2000-09-08 WO PCT/GB2000/003460 patent/WO2001018052A1/en active IP Right Grant
- 2000-09-08 EP EP00962653A patent/EP1210369A1/en not_active Withdrawn
- 2000-09-08 PL PL00354488A patent/PL354488A1/xx not_active Application Discontinuation
- 2000-09-08 AU AU74305/00A patent/AU767006B2/en not_active Ceased
-
2002
- 2002-03-07 NO NO20021135A patent/NO20021135D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1287124A (zh) | 2001-03-14 |
| IL148380A0 (en) | 2002-09-12 |
| BR0013840A (pt) | 2002-07-02 |
| MXPA02002489A (es) | 2002-08-28 |
| US6800606B1 (en) | 2004-10-05 |
| PL354488A1 (en) | 2004-01-26 |
| AU7430500A (en) | 2001-04-10 |
| CN1125081C (zh) | 2003-10-22 |
| NO20021135L (no) | 2002-03-07 |
| JP2003525867A (ja) | 2003-09-02 |
| NO20021135D0 (no) | 2002-03-07 |
| CA2383638A1 (en) | 2001-03-15 |
| EP1210369A1 (en) | 2002-06-05 |
| WO2001018052A1 (en) | 2001-03-15 |
| CZ20021227A3 (cs) | 2002-07-17 |
| AU767006B2 (en) | 2003-10-30 |
| TR200200599T2 (tr) | 2002-05-21 |
| HUP0202793A3 (en) | 2005-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1276722B1 (it) | Formulazioni di analoghi monomerici dell'insulina | |
| WO2003105695A3 (en) | MECHANICAL STRUCTURES AND IMPLANTS INCLUDING SAID STRUCTURES | |
| HUP0003314A2 (hu) | GLP-1 analógok és származékok alkalmazása elhízás szabályozására használható gyógyszerkészítmények előállítására | |
| BR9906796A (pt) | Método para a administração de análogos de insulina monoméricos | |
| BR9607935A (pt) | Formulações de análogos de insulina monoméricos | |
| EP2022505A3 (en) | GLP-1, exendin-4, peptide analogs and uses thereof | |
| ITMI951278A0 (it) | Formulazioni di analoghi dell'insulina | |
| NO975513L (no) | 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel | |
| ATE62507T1 (de) | Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert. | |
| DK1126881T3 (da) | Mucoadhæsive polymerer, anvendelse deraf samt fremstillingsmåde deraf | |
| FR2863867B1 (fr) | Prothese interphalangienne et/ou metacarpophalangienne | |
| DE69814394D1 (de) | Verwendung von levobupivacain | |
| DK0601154T3 (da) | BPC-peptider, deres fremstilling og anvendelse | |
| HUP0202793A2 (hu) | A humán inzulin monomer analógjai | |
| AU2003286404A8 (en) | Peptide nanostructures, methods for their preparation and use | |
| NO179852C (no) | Blanding som omfatter 1,2-benzisotiazolin-3-on og anvendelse derav | |
| IT1238825B (it) | Dispositivo per la correzione chirurgica dell'ametropia. | |
| ATE77628T1 (de) | Peptidverbindungen. | |
| DK1284994T3 (da) | Anvendelse af et ekstracellulært hæmoglobin med höj molekylvægt som blodsubstitut | |
| NO307757B1 (no) | Uretanholdige aminosteroidforbindelser, farmasøytisk preparat samt anvendelse | |
| UY24780A1 (es) | Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación. | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| ATE499383T1 (de) | Eine methode zur herstellung von menschlichem natürlichem interferon-alpha | |
| IT1286307B1 (it) | Virus mixomatoso ricombinante, suo impiego per la produzione di un vaccino e relativo vaccino. | |
| IT1312060B1 (it) | Uso dell'acido alfa lipoico nel trattamento antimetastatico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |